Hepatitis C virus variants

Details for Australian Patent Application No. 2006315438 (hide)

Owner Vertex Pharmaceuticals, Inc.

Inventors Kwong, Ann; Kieffer, Tara; Lin, Chao; Sarrazin, Christoph

Agent Cullen & Co

Pub. Number AU-A-2006315438

PCT Pub. Number WO2007/059221

Priority 60/854,598 25.10.06 US; 60/735,577 11.11.05 US

Filing date 13 November 2006

Wipo publication date 24 May 2007

International Classifications

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059221 Priority application(s): WO2007/059221

11 September 2008 Alteration of Name

  The name of the applicant has been altered to Vertex Pharmaceuticals Incorporated

25 September 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 27 Aug 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315443-Photoactivatable antimicrobial agents

2006315436-Azaindazoles useful as inhibitors of kinases